Osteoarthritis Trials in St. Louis, United States
Conditions / Osteoarthritis / St. Louis, United States
Research into Osteoarthritis spans multiple therapeutic approaches and trial phases.
41 total trials for this combination
Showing top 10 of 41 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00420992 | A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee | COMPLETED | PHASE3 |
| NCT00744471 | Tanezumab in Osteoarthritis Of The Hip | COMPLETED | PHASE3 |
| NCT00809783 | Extension Study Of Tanezumab In Osteoarthritis | TERMINATED | PHASE3 |
| NCT02301234 | Study of Safety, Efficacy of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3007 | COMPLETED | PHASE3 |
| NCT00809354 | Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip | TERMINATED | PHASE3 |
| NCT00373685 | GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS) | COMPLETED | PHASE4 |
| NCT00487435 | An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain | COMPLETED | PHASE3 |
| NCT01094262 | A Safety and Tolerability Study of JNJ-42160443 in Patients With Moderate to Severe, Chronic Knee Pain From Osteoarthritis | TERMINATED | PHASE2 |
| NCT00228605 | Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain | COMPLETED | PHASE3 |
| NCT00733902 | Tanezumab in Osteoarthritis of the Knee | COMPLETED | PHASE3 |